Sep 3, 2024 7:00 am EDT Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer
Aug 13, 2024 7:00 am EDT Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
Aug 12, 2024 4:05 pm EDT Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Aug 7, 2024 5:11 pm EDT Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.
Jul 30, 2024 8:00 am EDT Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease
Jul 23, 2024 7:00 am EDT Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease